01952 EVEREST MED-B
- 22.750
- -1.050-4.41%
EVEREST MED-B News
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
EVEREST MED-B: VOLUNTARY ANNOUNCEMENT VOLUNTARY LOCK-UP UNDERTAKING BY CONTROLLING SHAREHOLDER AND CERTAIN SENIOR MANAGEMENT
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
EVEREST MED-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
EVEREST MED-B: CHANGE OF NON-EXECUTIVE DIRECTOR
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
EVEREST MED-B: VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE
EVEREST MED-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
EVEREST MED-B: CHANGE OF NON-EXECUTIVE DIRECTOR
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
EVEREST MED-B: VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON THE APPROVAL OF NEW DRUG APPLICATION IN CHINA FOR NEFECON FOR THE TREATMENT OF PRIMARY IMMUNOGLOBULIN A NEPHROPATHY IN ADULTS AT RISK OF DISEASE PROGRESSION
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
EVEREST MED-B: Next Day Disclosure Return
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
EVEREST MED-B: VOLUNTARY ANNOUNCEMENT COLLABORATION AND LICENSE AGREEMENT WITH KEZAR TO DEVELOP AND COMMERCIALIZE ZETOMIPZOMIB IN GREATER CHINA AND OTHER ASIAN MARKETS
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
EVEREST MED-B: Notification Letter with Request Form to Non-registered Holders
EVEREST MED-B: Notification Letter with Change Request Form to Registered Shareholders
EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Analysis
Price Target
No Data
